Dyslipidemia

Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in Qatar.

Dyslipidemia

Learn about the latest trends, discover events and innovations in the changing world of dyslipidemia disease.

Science in Dyslipidemia Disease

Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you

ODYSSEY Outcomes

NEJM Odyssey Outcomes

Odyssey Outcomes - Mortality

The EXPLORER Study

The ROSETTE Study

The ACTE Study

Odyssey Outcomes - CABG Results

Odyssey Outcomes - PVD Results

PCSK9 inhibitors and ACS

ESC/EAS 2019 International Guidelines

Odyssey Outcomes - Elderly Patients Results

Odyssey Outcomes - Total Events Results

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources

EAS guidance regarding combining lipid-modifying therapy

Lp(a) and PCSK9 inhibition in nominally controlled LDL-C

The Role of the Patient in Achieving LDL-C Target

Treating to target in clinical practice: Why is it important to achieve recommended LDL-C levels?

Events

Stay up to date and register for the latest events and view webinar recordings.

Dyslipidemia Webinars: Optimizing Dyslipidemia management

Dyslipidemia Webisodes: Mortality data with Prof. Tunon

Dyslipidemia Expert Exchange: Best practice approaches in dyslipidemia management

YOU WILL NOW BE LEAVING THE SITE

By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

Continue

This website is intended exclusively for healthcare professionals residing and/or working in the Qatar.

Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.